The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Prognostic Significance of Plasma Norepinephrine in Patients With Asymptomatic Left Ventricular Dysfunction
Abstract
Background Elevated plasma neurohormonal levels are associated with increased mortality rates in patients with symptomatic heart failure. A previous Studies of Left Ventricular Dysfunction (SOLVD) trial suggested that neurohumoral activation precedes the development of symptoms as demonstrated by increased neurohormonal levels in patients with asymptomatic left ventricular dysfunction. However, the significance of this early neurohumoral activation is unclear. The goals of this study were to determine the prognostic significance of the plasma concentrations of plasma norepinephrine (PNE) and atrial natriuretic peptide (ANP) and the renin activity (PRA) in patients with asymptomatic left ventricular dysfunction. Methods and Results PNE and PRA were measured before randomization in 514 patients with left ventricular ejection fractions ≤35% who did not require treatment for congestive heart failure and were enrolled in the SOLVD Prevention Trial. Plasma ANP levels were measured in a subset of 241 patients owing to study design. Using the Cox proportional hazards model that included left ventricular ejection fraction, New York Heart Association functional class, age, sex, treatment assignment to placebo or enalapril, and cause of heart failure, we examined whether these neurohormones predicted all-cause mortality, cardiovascular mortality, hospitalization for heart failure, development of heart failure, or development of ischemic events (myocardial infarction or unstable angina). PNE was the strongest predictor of clinical events in this patient population. PNE levels above the median of 393 pg/mL were associated with a relative risk of 2.59 ( P =.002) for all-cause mortality, 2.55 ( P =.003) for cardiovascular mortality, 2.55 ( P =.005) for hospitalization for heart failure, 1.88 ( P =.002) for development of heart failure, 1.92 ( P =.001) for ischemic events, and 2.59 ( P =.005) for myocardial infarction. PNE remained the most powerful predictor for all-cause mortality and ischemic events when the analysis included only the patients with histories of ischemic left ventricular dysfunction. The increases in other neurohormonal levels were not useful in predicting the subsequent development of clinical events. Conclusions Increased PNE levels in patients with asymptomatic left ventricular dysfunction appear to predict all-cause and cardiovascular mortalities and development of clinical events related to the onset of heart failure or acute ischemic syndromes. Thus, measurement of PNE may be a possible early marker for assessment of disease progression in patients with left ventricular dysfunction, and modulating the release or effect of PNE may lead to improved prognosis and/or a reduction in morbidity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725
Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure
Cohn, J. N., Levine, T. B., Olivari, M. T., Garberg, V., Lura, D., Francis, G. S., Simon, A. B., & Rector, T. (1984) · New England Journal of Medicine · doi:10.1056/nejm198409273111303 · Cited by 3,125
Self-citationFrancis, G. S., Benedict, C., Johnstone, D. E., Kirlin, P. C., Nicklas, J., Liang, C. S., Kubo, S. H., Rudin-Toretsky, E., & Yusuf, S. (1990) · Circulation · doi:10.1161/01.cir.82.5.1724 · Cited by 1,388
Self-citationBeneficial effects of metoprolol in idiopathic dilated cardiomyopathy
Waagstein, F., Hjalmarson, A., Swedberg, K., Bristow, M. R., Gilbert, E. M., Camerini, F., Fowler, M. B., Silver, M. A., Johnson, M. R., & Goss, F. G. (1993) · The Lancet · doi:10.1016/0140-6736(93)92930-r · Cited by 1,234
Swedberg, K., Eneroth, P., Kjekshus, J., & Wilhelmsen, L. (1990) · Circulation · doi:10.1161/01.cir.82.5.1730 · Cited by 1,153
Plasma norepinephrine in congestive heart failure
Thomas, J. A., & Marks, B. H. (1978) · The American Journal of Cardiology · doi:10.1016/0002-9149(78)90162-5 · Cited by 920
Leimbach, W. N., Wallin, B. G., Victor, R. G., Aylward, P. E., Sundlöf, G., & Mark, A. L. (1986) · Circulation · doi:10.1161/01.cir.73.5.913 · Cited by 812
Levine, T. B., Francis, G. S., Goldsmith, S. R., Simon, A. B., & Cohn, J. N. (1982) · The American Journal of Cardiology · doi:10.1016/0002-9149(82)90243-0 · Cited by 614
Self-citationLee, W. H., & Packer, M. (1986) · Circulation · doi:10.1161/01.cir.73.2.257 · Cited by 552
Cited by
Kitzman, D. W. (2002) · JAMA · doi:10.1001/jama.288.17.2144 · Cited by 883
Sympathetic Nervous System Overactivity and Its Role in the Development of Cardiovascular Disease
Malpas, S. C. (2010) · Physiological Reviews · doi:10.1152/physrev.00007.2009 · Cited by 699
Santos-Gallego, C. G., Requena-Ibanez, J. A., San Antonio, R., Ishikawa, K., Watanabe, S., Picatoste, B., Flores, E., Garcia-Ropero, A., Sanz, J., Hajjar, R. J., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.01.056 · Cited by 651
Richards, A. M., Nicholls, M. G., Yandle, T. G., Frampton, C., Espiner, E. A., Turner, J. G., Buttimore, R. C., Lainchbury, J. G., Elliott, J. M., Ikram, H., et al. (1998) · Circulation · doi:10.1161/01.cir.97.19.1921 · Cited by 646
Calmodulin kinase II inhibition protects against structural heart disease
Zhang, R., Khoo, M. S. C., Wu, Y., Yang, Y., Grueter, C. E., Ni, G., Price, E. E., Thiel, W., Guatimosim, S., Song, L.-S., et al. (2005) · Nature Medicine · doi:10.1038/nm1215 · Cited by 579
Exercise protects the cardiovascular system: effects beyond traditional risk factors
Joyner, M. J., & Green, D. J. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.179432 · Cited by 520
Zoccali, C., Mallamaci, F., Parlongo, S., Cutrupi, S., Benedetto, F. A., Tripepi, G., Bonanno, G., Rapisarda, F., Fatuzzo, P., Seminara, G., et al. (2002) · Circulation · doi:10.1161/hc1102.105261 · Cited by 519
Mente, A., O'Donnell, M., Rangarajan, S., Dagenais, G., Lear, S., McQueen, M., Diaz, R., Avezum, A., Lopez-Jaramillo, P., Lanas, F., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30467-6 · Cited by 483
Self-citationIncreased Sympathetic Nerve Activity in Pulmonary Artery Hypertension
Velez-Roa, S., Ciarka, A., Najem, B., Vachiery, J.-L., Naeije, R., & van de Borne, P. (2004) · Circulation · doi:10.1161/01.cir.0000140724.90898.d3 · Cited by 443
Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin
Richards, A. M., Doughty, R., Nicholls, M. G., MacMahon, S., Sharpe, N., Murphy, J., Espiner, E. A., Frampton, C., & Yandle, T. G. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01269-4 · Cited by 389
Racial Differences in the Outcome of Left Ventricular Dysfunction
Dries, D. L., Exner, D. V., Gersh, B. J., Cooper, H. A., Carson, P. E., & Domanski, M. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902253400804 · Cited by 368
Latini, R. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.10.030 · Cited by 344
Clerico, A., & Emdin, M. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.024760 · Cited by 333
Rutten, F. H. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.112 · Cited by 307
Established and Emerging Roles of Biomarkers in Heart Failure
Ibrahim, N. E., & Januzzi, J. L. (2018) · Circulation Research · doi:10.1161/circresaha.118.312706 · Cited by 306
Volpe, M., Carnovali, M., & Mastromarino, V. (2015) · Clinical Science · doi:10.1042/cs20150469 · Cited by 305
Central Sleep Apnea in Left Ventricular Dysfunction: Prevalence and Implications for Arrhythmic Risk
Lanfranchi, P. A., Somers, V. K., Braghiroli, A., Corra, U., Eleuteri, E., & Giannuzzi, P. (2003) · Circulation · doi:10.1161/01.cir.0000049641.11675.ee · Cited by 298
Choi, D.-J., Koch, W. J., Hunter, J. J., & Rockman, H. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.27.17223 · Cited by 261
The sympathetic/parasympathetic imbalance in heart failure with reduced ejection fraction
Floras, J. S., & Ponikowski, P. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv087 · Cited by 260
Triiodothyronine levels for risk stratification of patients with chronic heart failure
Pingitore, A., Landi, P., Taddei, M. C., Ripoli, A., L’Abbate, A., & Iervasi, G. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.07.052 · Cited by 192
Exner, D. V., Dries, D. L., Waclawiw, M. A., Shelton, B., & Domanski, M. J. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00675-5 · Cited by 172
Self-citationHeart rate, lifespan, and mortality risk
Zhang, G. Q., & Zhang, W. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2008.10.001 · Cited by 139
Curiati, J. A., Bocchi, E., Freire, J. O., Arantes, A. C., Braga, M., Garcia, Y., Guimarães, G., & Fo, W. J. (2005) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2005.11.465 · Cited by 119
Calvert, C. A., & Wall, M. (2001) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.2001.219.1084 · Cited by 24
Metadata
- Authors
- Benedict, C. R., Shelton, B., Johnstone, D. E., Francis, G., Greenberg, B., Konstam, M., Probstfield, J. L., & Yusuf, S.
- Venue
- Circulation
- Published
- 1996-08-15
- Volume
- 94
- Issue
- 4
- Pages
- 690-697
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1967340565
- Cited by
- 353
- References
- 26
- FWCI
- 11.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.